Conference call next Wednesday, Sep 20th at 4:30 to discuss presentation....
Dr. Figlin's complete presentation at the ESMO 2017 Congress is available for review on Argos' website at www.argostherapeutics.com. Argos plans to hold a conference call to discuss Dr. Figlin's presentation on Wednesday, September 20(th) at 4:30pm ET and will provide logistical information in a subsequent announcement. (Source: [url=https://globenewswire.com/news-release/2017/09/12/1117929/0/en/Argos-Therapeutics-Reports-on-Interim-Analysis-of-Phase-3-ADAPT-Trial-Presented-at-ESMO-2017-Congress.html]
Recommended to continue ADAPT trial because results not yet conclusive without more time. A month ago they stated they wouldn't be able to operate without more cash by this date. Would expect financing/dilution/buyout for them to continue trial. Like Lion has said - this is an option play.
This isn't a bull or a bear market anymore. Its a lion's market. The members of this site are the smartest investors out there. You have to be quick and agile and time your strikes - just as a lion would in the jungle